(NASDAQ: TNDM) Tandem Diabetes Care's forecast annual revenue growth rate of 5.62% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.71%.
Tandem Diabetes Care's revenue in 2025 is $1,001,719,000.On average, 7 Wall Street analysts forecast TNDM's revenue for 2025 to be $67,417,439,690, with the lowest TNDM revenue forecast at $66,941,074,920, and the highest TNDM revenue forecast at $67,764,476,493. On average, 7 Wall Street analysts forecast TNDM's revenue for 2026 to be $73,618,965,739, with the lowest TNDM revenue forecast at $71,974,324,814, and the highest TNDM revenue forecast at $74,921,029,445.
In 2027, TNDM is forecast to generate $79,730,827,099 in revenue, with the lowest revenue forecast at $77,271,028,077 and the highest revenue forecast at $82,880,713,129.